Zobrazeno 1 - 10
of 10
pro vyhledávání: '"G R Madsen"'
Autor:
M Attauabi, G R Madsen, F Bendtsen, J T Bjerrum, R Wilkens, K Theede, J F K F Ilvemark, T Boysen, J B Seidelin, J Burisch
Publikováno v:
Journal of Crohn's and Colitis. 17:i437-i440
Background The initial disease burden of Crohn’s disease (CD) is dissimilar across patients; however, the ability to capture and predict the disease burden at diagnosis is scarcely investigated. The aim of the current study was to describe the init
Autor:
G R Madsen, M Attauabi, R Wilkens, J F K F Ilvemark, K Theede, J T Bjerrum, F Bendtsen, J B Seidelin, T Boysen, J Burisch
Publikováno v:
Journal of Crohn's and Colitis. 17:i317-i318
Background The disease course of inflammatory bowel disease (IBD) is heterogeneous and unpredictable. Currently, we are unable to predict which patients will need IBD-related bowel resection in the first year after diagnosis. Intestinal Ultrasound (I
Autor:
M Attauabi, G R Madsen, F Bendtsen, R Wilkens, J F K F Ilvemark, K Theede, T Boysen, J T Bjerrum, J B Seidelin, J Burisch
Publikováno v:
Journal of Crohn's and Colitis. 16:i285-i287
Background The early course of ulcerative colitis (UC) and Crohn’s disease (CD) is difficult to predict, particularly regarding identifying patients for whom an indolent course might be expected. Therefore, we aimed to investigate the initial cours
Publikováno v:
Journal of Crohn's and Colitis. 16:i483-i484
Background Several studies have indicated a reduced efficacy of vedolizumab among patients with ulcerative colitis (UC) and Crohn’s disease (CD) previously exposed to biological therapies. The purpose of this study was to determine the efficacy and
Autor:
G R Madsen, R Wilkens, T Boysen, J Burisch, R Bryant, D Carter, K Gecse, C Maaser, G Maconi, K Novak, C Palmela, L J Nayahangan, M G Tolsgaard
Publikováno v:
Journal of Crohn's and Colitis. 16:i319-i320
Background Intestinal Ultrasound (IUS) is a non-invasive modality for monitoring disease activity in inflammatory bowel diseases (IBD). IUS training currently lacks well-defined standards and international consensus on IUS competency criteria. Hence,
Autor:
M Dorn-Rasmussen, M Attauabi, G R Madsen, A V Wewer, S Jansson, M M Knudsen, R Wilkens, J F K F Ilvemark, J W Bjerrum, K Theede, F Bendtsen, B Trine, J B Seidelin, J M Burisch
Publikováno v:
Journal of Crohn's and Colitis. 16:i556-i557
Background Denmark has one of the highest occurrences of inflammatory bowel disease (IBD) in the world, with reported incidence rates of 7.2 and 6.2 in paediatric ulcerative colitis (pUC) and 10 and 9.4 per 105 for girls and boys in Crohn’s disease
Publikováno v:
Journal of Crohn's and Colitis. 16:i568-i569
Background Inflammatory bowel disease (IBD) and periodontitis are chronic, progressive, inflammatory diseases with similarities in their respective pathogenesis, which involve a complex interplay between a dysbiotic microbiota and a dysregulated immu
Autor:
G R Madsen, M Attauabi, R Wilkens, J F K F Ilvemark, K Theede, J T Bjerrum, M Dorn-Rasmussen, S Jansson, A V Wewer, F Bendtsen, J B Seidelin, T Boysen, J Burisch
Publikováno v:
Journal of Crohn's and Colitis. 16:i059-i060
Background The disease course of inflammatory bowel disease (IBD) is heterogeneous and highly unpredictable. Intestinal Ultrasound (IUS) is a non-invasive modality capable of assessing disease activity in IBD. IUS is reliable, patient-friendly, and a
Autor:
J Revés, B Abreu, M Chaparro, J P Gisbert, A Mariangela, G Fiorino, B Barberio, F Zingone, A Pisani, D Cassar, G Michalopoulos, G Mantzaris, K Mountaki, I Koutroubakis, K Karmiris, K Katsanos, D Ďuricova, J Burisch, G R Madsen, C Maaser, A Naila, E Orfanoudaki, V Milivojevic, A Buisson, L Avedano, S Leone, J Torres, P Ellul
Publikováno v:
Journal of Crohn's and Colitis. 16:i558-i558
Background Pivotal anti-SARS-CoV-2 vaccines clinical trials did not include patients with immune-mediated conditions such as inflammatory bowel disease (IBD). We aimed to describe the implementation of anti-SARS-CoV-2 vaccines among IBD patients, pat
Autor:
Marcin Włodarczyk, E. Brunet, A. Eek, P R Harvey, Andreas Blesl, Radislav Nakov, G E Gîlcă-Blanariu, L. Gilroy, G R Madsen, M. Lessing, Bram Verstockt, Jonathan Segal, P Schreiber, T. Konikoff, Maksimaityte, Milivojevic, Iago Rodríguez-Lago, N. Benech, Hubert Zatorski, Ivana Mikolašević, Lanska, Skuja, T L Capela, A. Kagramanova, Haluk Tarik Kani, D. Noviello, Á V. Patai, Brigida Barberio, J. Král, C Frias-Gomes, Florian Tran, D. Oliinyk, M Truyens, Lauranne A A P Derikx, Gabriele Dragoni, A A Protopapas, M. Miasnikova
Publikováno v:
Journal of Crohn's and Colitis. 15:S075-S076
Background More than 2.5 million people in Europe suffer from inflammatory bowel diseases (IBD). IBD affects the quality of life, but also has important consequences for health systems. As IBD care and education might differ and might be linked to Gr